疾病
医学
重症监护医学
流行病学
心理干预
糖尿病
疾病管理
自身免疫性疾病
慢性病
内科学
免疫学
2型糖尿病
梅德林
内分泌学
生物
精神科
帕金森病
生物化学
作者
Linda A. DiMeglio,Carmella Evans‐Molina,Richard A. Oram
出处
期刊:The Lancet
[Elsevier]
日期:2018-06-01
卷期号:391 (10138): 2449-2462
被引量:926
标识
DOI:10.1016/s0140-6736(18)31320-5
摘要
Type 1 diabetes is a chronic autoimmune disease characterised by insulin deficiency and resultant hyperglycaemia. Knowledge of type 1 diabetes has rapidly increased over the past 25 years, resulting in a broad understanding about many aspects of the disease, including its genetics, epidemiology, immune and β-cell phenotypes, and disease burden. Interventions to preserve β cells have been tested, and several methods to improve clinical disease management have been assessed. However, wide gaps still exist in our understanding of type 1 diabetes and our ability to standardise clinical care and decrease disease-associated complications and burden. This Seminar gives an overview of the current understanding of the disease and potential future directions for research and care.
科研通智能强力驱动
Strongly Powered by AbleSci AI